Delivery Order HHSN261201200026I-HHSN26100001

This is a firm-fixed-price delivery order awarded by the National Cancer Institute (NCI), part of the Department of Health and Human Services (HHS), to Southern Research Institute, a non-profit research organization. The contract is for "PRECLINICAL PHARMACOLOGY AND TOXICOLOGY STUDIES - CONTRACT ORIENTATION MEETING WITH NCI, OFFICE OF ACQUISITIONS" and is part of a larger Preclinical Pharmacology and Toxicology Studies 2012-2014 contract vehicle. The award has a ceiling value of $4,010...

This is a $1,010.00 firm fixed-price delivery order awarded by the National Cancer Institute (NCI) to the IIT Research Institute (IITRI), a non-profit contract research organization. The contract is for a "Kick Off Meeting, Preclinical Pharmacokinetic & Pharmacology Evaluations of Agents Being Developed for Cancer Patients" with a performance period from July 1, 2016 to September 30, 2016. This work is being performed under NCI's Pharmacokinetic and Pharmacology Evaluations for...

This is a delivery order worth $3,102 awarded by the National Cancer Institute (NCI) to Battelle Memorial Institute, a nonprofit research and development organization, for a contract orientation meeting related to preclinical pharmacology and toxicology studies. The delivery order was issued under a larger Preclinical Pharmacology and Toxicology Studies contract vehicle that runs from 2012 to 2014. The award does not have a set-aside designation. Battelle frequently partners with universities...

This federal contract award is for an "OTHER FUNCTIONS - CONTRACT ORIENTATION MEETING WITH NCI, OFFICE OF ACQUISITIONS" valued at $4,144.00. The award was made by the National Cancer Institute (NCI), which is part of the U.S. Department of Health and Human Services, to the prime contractor Sri International, a non-profit research and development institute. The contract is a Delivery Order under the Preclinical Efficacy and Intermediate Endpoint Biomarkers contract vehicle. Sri...

This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit contract research organization. The $4,145 contract is for a pre-clinical toxicology study of a drug developed for cancer patients, as part of the Toxicology of Drugs Developed for Cancer Patients contract vehicle. IITRI specializes in preclinical drug development services and has...

This firm fixed-price purchase order was awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health within the Department of Health and Human Services, to Pharmaron, Inc. for $64,090. The contract is for Pharmaron to conduct a 14-day dose range-finding toxicity study in male and female rats to determine the maximally tolerated dose of an investigational molecule under development by NCATS. Specifically, Pharmaron will test the...

This is a delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to IIT Research Institute (IITRI), a non-profit contract research organization. The $1,259,678.78 contract is to provide support for the preclinical development of an endoxifen gel, including pharmacology, toxicology, and safety studies to support an Investigational New Drug (IND) application. This contract is part of the NCI's PREVENT...

This task order was awarded under the PREVENT Preclinical Drug Development Program multiple award contract vehicle by the National Cancer Institute, part of the National Institutes of Health within the Department of Health and Human Services. The task order, valued at approximately $2,400, is for a contract orientation and kickoff meeting to be provided by IIT Research Institute, the prime contractor, located in Chicago, Illinois. The period of performance is January 25, 2019 through February...

This is a delivery order under the Toxicology of Drugs Developed for Cancer Patients contract vehicle, awarded by the National Cancer Institute (NCI) to Battelle Memorial Institute. The $248,269.21 cost-plus-fixed-fee contract is for a pre-clinical toxicity study to characterize the toxicity of potential anticancer compounds following multiple dose administration to rats. The contract runs from January 18, 2017 to June 30, 2018. No set-aside designation is mentioned. Battelle frequently serves...

This firm fixed-price purchase order was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Cyprotex US LLC, a foreign-owned for-profit contract research organization. The $157,158 contract is for the characterization of absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties of small-molecule drug candidates using standardized in vitro methods. This work supports...